secwatch.observer — SEC 8-K summary
======================================

Issuer:     MESA LABORATORIES INC /CO/ (MLAB)
CIK:        0000724004
Form:       8-K
Filed at:   2026-05-27T12:00:13+00:00
Accession:  0000724004-26-000039
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mesa Labs Q4 revenue up 2.6% but net loss $4.1M; BPD revenue falls 29.9% on export controls
--------------------------------------------------------------------------------

- Q4 revenue $63.7M (+2.6% YoY); net loss $4.1M ($0.75 loss per share) vs prior year loss of $7.1M.
- Non-GAAP AOI margin 28.7% (vs 19.7% last year) driven by SDC backlog clearance and cost actions.
- BPD division revenue declined 29.9% due to export controls delaying Peptide system shipments; BPD core organic -31.6%.
- SDC organic growth 17.7% aided by ~$2M backlog reduction; full-year SDC organic 8.7%.
- Repaid $14.7M debt in Q4; net leverage ratio 2.11; CFO expects overall core organic growth positive in Q1 FY27.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/724004/000072400426000039/0000724004-26-000039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/724004/000072400426000039/mlab20260526_8k.htm
  HTML page:      https://secwatch.observer/filing/0000724004-26-000039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer